$VRAX +18% 🚀 Virax Biolabs starting to wake up 🔹 Biotech name focused on immune diagnostics, including ViraxImmune for post-acute infection syndromes 🧬 🔹 Cl

$VRAX +18% 🚀 Virax Biolabs starting to wake up 🔹 Biotech name focused on immune diagnostics, including ViraxImmune for post-acute infection syndromes 🧬 🔹 Clinical validation data expected in Q2 2026 — key catalyst window is getting closer 📅 🔹 Prior updates showed UK studies fully enrolled + Em…